This is an intriguing case of metastatic melanoma which demonstrated a promising result of achieving complete tumor resolution with the addition of low-dose radiation therapy (L-XRT) despite its initial resistance to anti-PD1 immunotherapy. Here, PDCD1 is linked to neoplasm.